Article ID Journal Published Year Pages File Type
8712931 Journal of Allergy and Clinical Immunology 2018 17 Pages PDF
Abstract
The Serpins Spi2A in mice and SERPINB3 and SERPINB4 in allergic patients control the viability of TH2 cells. This provides proof of principle for a therapeutic approach for allergic disease through ablation of allergic memory TH2 cells through SERPINB3 and SERPINB4 mRNA downregulation.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , , , ,